Infectious Disease

Home Infectious Disease
Vaccination with recombinant zoster vaccine seems cost-effective under a wide range of conditions

Recombinant Zoster Vaccine Cost-Effective in Simulation

Incremental cost-effectiveness ratio varied from $10,000 to $47,000 per QALY for RZV versus no vaccine
A substantial proportion of heterosexual syphilis transmission seems to be occurring among those who use drugs

CDC: Heterosexual Syphilis Transmission Up for Drug Users

Substantial proportion of heterosexual syphilis transmission seen in drug users, especially meth users
Growth in hospital prices and payments outpaced growth in physician prices and payments from 2007 through 2014

Hospital Prices Growing Faster Than Physician Prices

Efforts to reduce health care spending should focus on hospital prices
More than half of hospitalized patients who die or are terminally discharged have sepsis

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease
For patients colonized with methicillin-resistant Staphylococcus aureus (MRSA)

Risk for MRSA Reduced With Postdischarge Decolonization

Risk for MRSA infections, infections from any cause further reduced with full adherence to decolonization
A higher frequency of enterovirus infections in early childhood is associated with an increased risk for developing celiac disease

Child Enterovirus Infection May Up Risk for Developing Celiac Disease

Correlation seen for infections after introduction of gluten; no link for adenovirus
Achieving high serogroup B meningococcal vaccination coverage is recommended following university-based outbreaks of meningococcal disease caused by serogroup B

High Rates of MenB Vaccination Advised in University Outbreaks

Estimated first-dose vaccination coverage varied from 14 to 98 percent in 10 university outbreaks
The 2018 to 2019 influenza season has been low in severity so far

CDC: Severity of Influenza Season Low Through Feb. 2, 2019

Vaccine effectiveness 47 percent against all flu virus infection associated with acute respiratory illness
Sinks next to toilets in hospital patient rooms may be reservoirs for Klebsiella pneumonia carbapenemase

Sinks by Toilets in ICU Patient Rooms Harbor Harmful Bacteria

Klebsiella pneumonia carbapenemase more common in sinks near toilets
Although there has been progress in the development of new antibacterial drugs

Progress Made in Developing New Antibacterial Agents

But most recently approved agents have been modifications of existing chemical classes of antibiotics